EURONEXT:ABNX
ABIONYX Pharma SA
- Stock
Last Close
1.28
30/08 15:14
Market Cap
39.38M
Beta: 0.27
Volume Today
6.31K
Avg: 123.73K
PE Ratio
−7.77
PFCF: −10.89
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.27M - | -2.55M 100% | -1.64M 35.66% | -3.28M 100% | -1.27M 61.08% | -2.55M 100% | -825K 67.65% | -1.66M 100.73% | -1.12M 32.13% | -2.25M 100% | -626K 72.15% | -626K 0% | |
depreciation and amortization | 38K - | 59K 55.26% | 72K 22.03% | 301K - | -47.50K 115.78% | 324K 782.11% | 37.50K 88.43% | 255K 580% | -37.50K 114.71% | -37.50K 0% | |||
deferred income tax | -789K - | -461K - | -447K - | ||||||||||
stock based compensation | 14K - | 14K 0% | 393.50K 2,710.71% | 393.50K 0% | 187K 52.48% | 187K 0% | -187K 200% | -187K 0% | -63K 66.31% | -63K 0% | 63K 200% | 63K 0% | |
change in working capital | -1.76M - | -872K 50.51% | 18K 102.06% | -1.56M - | 1.66M - | -216K - | 108K 150% | 108K 0% | |||||
accounts receivables | -47.50K - | -47.50K 0% | |||||||||||
inventory | 3K - | 3K 0% | |||||||||||
accounts payables | |||||||||||||
other working capital | -881K - | -827.50K 6.07% | -827.50K 0% | 108K - | 108K 0% | ||||||||
other non cash items | -876K - | 78K 108.90% | 846.50K 985.26% | 906K 7.03% | -592K 165.34% | 840K 241.89% | 1.15M 36.43% | 535K 53.32% | -120K 122.43% | 180K 250% | -88K 148.89% | -88K 0% | |
net cash provided by operating activities | -2.13M - | -4.27M 99.91% | -1.21M 71.63% | -2.42M 100.17% | -1.68M 30.69% | -3.57M 112.68% | 86.50K 102.42% | 214K 147.40% | -1.27M 693.22% | -2.54M 100% | -580.50K 77.14% | -580.50K 0% | |
investments in property plant and equipment | -11K - | -83K 654.55% | -155K 86.75% | -118K - | 59K 150% | -57K 196.61% | -34K 40.35% | -71K 108.82% | 34K 147.89% | 34K 0% | |||
acquisitions net | 3K - | 1.50M - | |||||||||||
purchases of investments | |||||||||||||
sales maturities of investments | |||||||||||||
other investing activites | -5K - | 1.50K 130% | 757K 50,366.67% | 757K 0% | -90K 111.89% | -100K - | -1.50K - | -48.50K - | -48.50K 0% | ||||
net cash used for investing activites | -5K - | -8K 60% | 674K 8,525% | 1.35M 99.70% | -90K 106.69% | -118K 31.11% | -41K 65.25% | -57K 39.02% | -35.50K 37.72% | -71K 100% | -14.50K 79.58% | -14.50K 0% | |
debt repayment | -118K - | -118K - | -481K - | ||||||||||
common stock issued | 4.06M - | 47K - | -5K - | 13K - | |||||||||
common stock repurchased | -47K - | -18K - | -23.50K - | -23.50K 0% | -6.50K - | -6.50K 0% | |||||||
dividends paid | -88K - | ||||||||||||
other financing activites | -25K - | 2.01M - | 2.01M 0% | -95K 104.72% | -35.50K 62.63% | -41K 15.49% | 111.50K 371.95% | 247K 121.52% | 1.71M - | 1.71M 0% | |||
net cash used provided by financing activities | -25K - | -47K 88% | 2.01M 4,378.72% | 4.02M 99.85% | -95K 102.36% | -71K 25.26% | -64.50K 9.15% | -123K 90.70% | 247K 300.81% | 494K 100% | 1.70M 244.74% | 1.70M 0% | |
effect of forex changes on cash | -145.00K - | -16.00K - | 4K - | ||||||||||
net change in cash | -2.17M - | -4.32M 99.68% | 1.47M 134.10% | 3.10M 110.58% | -1.86M 160.08% | -3.91M 109.49% | -19K 99.51% | 18.00K 194.74% | -1.06M 5,977.45% | -2.11M 99.62% | 1.11M 152.46% | 1.11M 0% | |
cash at beginning of period | 9.15M - | 4.83M - | 7.93M - | 4.03M - | 4.05M - | ||||||||
cash at end of period | -2.17M - | 4.83M 323.14% | 1.47M 69.49% | 7.93M 438.33% | -1.86M 123.50% | 4.03M 315.98% | -19K 100.47% | 4.05M 21,394.74% | -1.06M 126.15% | 1.93M 282.80% | 1.11M 42.71% | 1.11M 0% | |
operating cash flow | -2.13M - | -4.27M 99.91% | -1.21M 71.63% | -2.42M 100.17% | -1.68M 30.69% | -3.57M 112.68% | 86.50K 102.42% | 214K 147.40% | -1.27M 693.22% | -2.54M 100% | -580.50K 77.14% | -580.50K 0% | |
capital expenditure | -11K - | -83K 654.55% | -155K 86.75% | -118K - | 59K 150% | -57K 196.61% | -34K 40.35% | -71K 108.82% | 34K 147.89% | 34K 0% | |||
free cash flow | -2.13M - | -4.28M 100.42% | -1.29M 69.76% | -2.58M 99.30% | -1.68M 34.86% | -3.69M 119.70% | 145.50K 103.94% | 157K 7.90% | -1.30M 930.25% | -2.61M 100.23% | -546.50K 79.06% | -546.50K 0% |
All numbers in EUR (except ratios and percentages)